The Sheba Cancer Center and Institute of Oncology, headed by Dr. Raanan Berger, is one of the largest cancer centers in Israel, integrating sophisticated clinical methods with compassionate and supportive attitude to cancer treatment. The ultra-modern center treats more than 4,500 new patients a year, and handles more than 40,000 patient visits per year. The center operates cancer treatment clusters in breast, lung, and gastrointestinal cancers, melanoma, uro-oncology, neuro-oncology and other cancers.
Aside from providing clinical treatment, the Sheba Cancer Center operates at the translational level in order to provide the basis for innovative clinical research programs (both external and internally developed).
The division includes the following units:
• Radiotherapy unit, including stereotactic radiotherapy & radiosurgery and IMRT
• Brachytherapy unit
• Breast unit
• Melanoma unit (The Ella Institute for Treatment and Research of Melanoma and Skin Cancer)
• Lung unit
• Gastrointestinal unit
• Uro-oncology and
• Neuro-oncology unit
• Clinical Research Studies Unit
• The Riva and Joel Koschitzky Solid Tumor Treatment Unit
The institute clinical activity includes:
• The Riva Koschitzky Oncology Clinical Research Unit.
• The Sigi Ziering Oncological Day Clinic (in memory of Sigi Ziering) with 25,000 visits.
• An outpatient clinic with 4,500 new visits, and 37,000 outpatient clinical sessions.
• A 30-bed in-patients ward (over 1,000 patients annually).
• A modern radiation therapy facility, with 2,500 new radiotherapy patients a year, over 180 patients every day.
• Brachytherapy unit, with 300 patients per year.
• The Palliative Care Unit, which operates jointly with the hospice.
Clinical research activity is growing rapidly, and in the last year more 480 patients participated in 48 studies, including phase I, II, and III.
Examples of some of the important clinical trials in which we participated include the recent multi-center herceptin and lapatinib clinical trials in breast cancer lead by Dr. Bella Kaufman and the tumor infiltrating lymphocytes (TIL) studies in melanoma lead by Prof. Jacob Schachter.
| Institute at a Glance |
| Number of Inpatients per Year - 1000 |
| Number of Outpatients per Year - 2500 |
| Number of Beds - 28 (Inpatients) and 15 Daycare Beds |
|
Director - DR. Raanan Berger |
| Address - The Institute is Located at The Cancer Center. The Inpatient Department is Located on The Charles Clore Hospitalization Tower. |
| E-mail - Raanan.Berger@sheba.health.gov.il |
| Tel - 972-3-530-2542 |
|
